Watson David O. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Apellis (APLS) General Counsel David Watson Receives RSU Award
What Happened
David O. Watson, General Counsel of Apellis Pharmaceuticals (APLS), received a grant of 55,986 restricted stock units (RSUs) on January 28, 2026. The RSUs were reported as an award/acquisition (code A) with a grant price of $0.00 (typical for RSU awards, not an open‑market purchase).
Key Details
- Transaction date: January 28, 2026; Form 4 filed January 30, 2026 (timely filing).
- Instrument: 55,986 Restricted Stock Units (RSUs) granted; reported acquisition price $0.00.
- Vesting: 25% of the award vests annually over four years from the grant date (footnote F1); vesting is subject to continued service.
- Ownership after transaction: not specified in the provided filing details.
- Related footnotes: holdings associated with minor children (custodial account, F2) and two trusts (The David O. Watson Irrevocable Trust of 2023 with trustee William Zorn, F3; The Watson Education Trust, F4). The reporting person disclaims beneficial ownership of shares held by those trusts except to the extent of any pecuniary interest.
- Transaction code: A = Award/Grant.
Context
RSU grants are a common form of executive compensation and do not involve an immediate cash purchase or sale. Because vesting is spread over four years, these awards typically serve as retention incentives rather than a direct market signal. The $0.00 acquisition price is standard for RSU grants and reflects that shares are delivered upon vesting, not bought on the open market.
Insider Transaction Report
- Award
Common Stock
[F1]2026-01-28+55,986→ 144,517 total
- 10,000(indirect: By Children)
Common Stock
[F2] - 50,136(indirect: By Trust)
Common Stock
[F3] - 0(indirect: By Trust)
Common Stock
[F4]
Footnotes (4)
- [F1]This represents a Restricted Stock Unit award granted on January 28, 2026 that vest 25% annually over four years from grant date subject to continued service.
- [F2]This represents a custodial account held by the reporting person for the sole benefit of his minor children.
- [F3]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F4]The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.